nimodipine has been researched along with Kidney Diseases in 3 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Mean terminal elimination half-life of nimodipine was 2." | 1.27 | Clinical pharmacokinetics of nimodipine in normal and impaired renal function. ( Dührsen, U; Kirch, W; Ohnhaus, EE; Rämsch, KD, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, J | 1 |
| Cao, H | 1 |
| Zhang, Y | 2 |
| Ma, J | 1 |
| Wang, J | 1 |
| Gao, Y | 1 |
| Zhang, X | 1 |
| Zhang, F | 1 |
| Chu, L | 1 |
| Fröba, G | 1 |
| Bracht, H | 1 |
| Hauser, B | 1 |
| Chkhouta, AB | 1 |
| Huber-Lang, M | 1 |
| Rittirsch, D | 1 |
| Brückner, UB | 1 |
| Radermacher, P | 1 |
| Schelzig, H | 1 |
| Kirch, W | 1 |
| Rämsch, KD | 1 |
| Dührsen, U | 1 |
| Ohnhaus, EE | 1 |
3 other studies available for nimodipine and Kidney Diseases
| Article | Year |
|---|---|
Nephroprotective effect of calcium channel blockers against toxicity of lead exposure in mice.
Topics: Animals; Apoptosis; Blood Urea Nitrogen; Body Weight; Calcium Channel Blockers; Creatinine; Cytoprot | 2013 |
Effects of intrarenal administration of the calcium antagonist nimodipine during porcine aortic occlusion-induced ischemia/reperfusion injury.
Topics: Animals; Aorta; Apoptosis; Calcium; Calcium Channel Blockers; Cyclin-Dependent Kinase Inhibitor p21; | 2008 |
Clinical pharmacokinetics of nimodipine in normal and impaired renal function.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; | 1984 |